UK markets close in 3 minutes

Baxter International Inc. (0QK8.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
60.48+0.37 (+0.62%)
As of 02:35PM BST. Market open.

Baxter International Inc.

One Baxter Parkway
Deerfield, IL 60015
United States
224 948 2000
https://www.baxter.com

Sector(s)
Industry
Full-time employees60,000

Key executives

NameTitlePayExercisedYear born
Mr. Jose E. AlmeidaChairman, Pres & CEO3.72MN/A1962
Mr. James K. SaccaroExec. VP & CFO1.62MN/A1973
Mr. Giuseppe AccogliExec. VP & COO1.78MN/A1971
Mr. Cristiano FranziSr. VP & Pres for EMEA1.76MN/A1963
Mr. Brian C. StevensSr. VP, Chief Accounting Officer & ControllerN/AN/A1975
Mr. Talvis P. LoveSr. VP & Chief Information OfficerN/AN/A1969
Ms. Clare TrachtmanVP of Investor RelationsN/AN/AN/A
Mr. David S. RosenbloomSr. VP & Gen. CounselN/AN/AN/A
Ms. Stacey EisenSr. VP of Global CommunicationsN/AN/AN/A
Ms. Jeanne K. MasonSr. VP of HRN/AN/A1956
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Corporate governance

Baxter International Inc.’s ISS governance QualityScore as of 31 July 2022 is 9. The pillar scores are Audit: 10; Board: 8; Shareholder rights: 6; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.